Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T16:11:44.793Z.
Calculation as of: 2026-10-06T16:11:44.793Z.
Quote observation: 2026-10-06T16:06:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 83c838c5f02617604a06e7cb0420d823d591f860cb8694f5d9431dbed4021aaa
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$2.69M
Price/OCF Ratio
5.03
TTM Avg
16.55
3Y Avg
669.72
5Y Avg
669.72
Market Cap
$2.92M
Price/OCF Ratio
N/A
TTM Avg
93.37
3Y Avg
1547.51
5Y Avg
1547.51
Market Cap
$2.93M
Price/OCF Ratio
N/A
TTM Avg
2.49
3Y Avg
2.49
5Y Avg
2.49
Market Cap
$2.30M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DEFSEC Technologies Inc. (DFSC) | $2.72M | N/A | N/A | N/A | N/A |
| Top KingWin Ltd. Class A (DPU)vs › | $2.73M | N/A | N/A | N/A | N/A |
| Globavend Holdings Limited (GVH)vs › | $2.69M | 5.03 | 16.55 | 669.72 | 669.72 |
| BioNexus Gene Lab Corp. (BGLC)vs › | $2.92M | N/A | 93.37 | 1547.51 | 1547.51 |
| PTL Limited (PTLE)vs › | $3.03M | N/A | N/A | N/A | N/A |
| Intelligent Group Limited (INTJ)vs › | $2.93M | N/A | 2.49 | 2.49 | 2.49 |
| Ping An Biomedical Co., Ltd. (PASW)vs › | $2.30M | N/A | N/A | N/A | N/A |
| Polar Power, Inc. (POLA)vs › | $3.14M | N/A | 810.88 | 810.88 | 810.88 |
| Mint Incorporation Limited (MIMI)vs › | $2.16M | N/A | N/A | N/A | N/A |
| Professional Diversity Network, Inc. (IPDN)vs › | $2.12M | N/A | 150.56 | 146.91 | 146.91 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
